Andrew Bryant
ASO PROF
MD-MEDICINE
GRANTS
- GRANTNovel Involvement of eNAMPT/TLR4 Signaling in PAH Vascular Remodeling and Right Ventricular DysfunctionNational Institute of Health Nhlbi9 Sep 2025 - 30 Jun 2029
- GRANTTuning complement-mediated immunity in aspergillosis: a systems medicine approachNational Institute of Health Niaid7 Dec 2023 - 30 Nov 2028
- GRANTNeuroimmune axis contribution to the pathophysiology of pulmonary hypertensionNational Institute of Health Nhlbi31 Mar 2023 - 14 Jul 2024
- GRANT2022 Student Scholarships in Cardiovascular Disease27 May 2022 - 30 May 2023
- GRANTMyeloid cell senescence in the development of pulmonary hypertensionBayer Healthcare Pharmaceuticals25 Jun 2020 - 6 Aug 2023
- GRANTRole of ADAM17 in MDSC-Mediated Development of Pulmonary HypertensionNational Institute of Health Nhlbi5 Apr 2020 - 31 Mar 2026
- GRANTInvolvement of Neuroinflammation in Pulmonary HypertensionAmerican Heart Association1 Dec 2019 - 31 Dec 2021
- GRANTRole of CXCR2-mediated cell trafficking in pulmonary vascular remodelingNational Institute of Health Nhlbi1 Aug 2019 - 31 Jul 2025
- GRANTRole of myeloid-derived suppressor cells in pulmonary hypertension associated with pulmonary fibrosisNational Institute of Health Nhlbi13 Jul 2018 - 31 Jan 2020
- GRANTRole of MDSCs in pulmonary hypertension associated with pulmonary fibrosisParker B Francis Fellowship Foundation9 Feb 2018 - 30 Jun 2021
- GRANTRole of CXCR2-mediated cell trafficking in pulmonary hypertensionAmerican Lung Association1 Jul 2017 - 31 Dec 2019
- GRANTRole of myeloid-derived suppressor cell trafficking in development of pulmonary hypertensionGilead Sciences16 Jun 2017 - 31 Dec 2019
- GRANTRole of myeloid-derived suppressor cell trafficking in development of pulmonary hypertensionLandenberger Research Foundation, Margaret Q.15 Feb 2017 - 31 Dec 2018